Literature DB >> 879733

In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.

T C Eickhoff, J M Ehret.   

Abstract

The in vitro activity of netilmicin was compared with that of gentamicin, tobramycin, amikacin, and kanamycin against 636 strains of bacteria recently isolated from clinical sources. Gentamicin was the most active antibiotic, but netilmicin and tobramycin closely paralleled it. Netilmicin was generally four-to eightfold less active than gentamicin against Serratia and group A streptococci, and was twofold less active against Pseudomonas aeruginosa. When effects of inoculum size and concentration of divalent cations in the media were evaluated, netilmicin was shown to be similar to gentamicin in vitro. Minimum inhibitory concentrations for P. aeruginosa were increased as much as 18-fold when the Mg(2+) and Ca(2+) concentrations were increased to physiological levels in Mueller-Hinton broth.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879733      PMCID: PMC352076          DOI: 10.1128/AAC.11.5.791

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Agranulocytosis associated with gentamicin.

Authors:  J C Chang; B Reyes
Journal:  JAMA       Date:  1975-06-16       Impact factor: 56.272

2.  GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS.

Authors:  J O KLEIN; T C EICKHOFF; M FINLAND
Journal:  Am J Med Sci       Date:  1964-11       Impact factor: 2.378

3.  LABORATORY AND CLINICAL STUDIES OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

Authors:  R J BULGER; S SIDELL; W M KIRBY
Journal:  Ann Intern Med       Date:  1963-11       Impact factor: 25.391

4.  New antibacterial treatment of nosocomial infections.

Authors:  T C Eickhoff
Journal:  Bull N Y Acad Med       Date:  1975-10

5.  Nephrotoxicity of aminoglycosides and gentamicin.

Authors:  F G Falco; H M Smith; G M Arcieri
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

Review 6.  Current therapeutics. 234. Gentamicin.

Authors:  G G Jackson
Journal:  Practitioner       Date:  1967-06

7.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

8.  Letter: Activities of tobramycin and amikacin against gentamicin-resistant gram-negative bacilli.

Authors:  E T Houang; E McKay-Ferguson
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

9.  Letter: Gentamicin-resistant Staphylococci.

Authors:  R E Warren; S O Roberts
Journal:  Lancet       Date:  1976-03-06       Impact factor: 79.321

10.  Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.

Authors:  R D Meyer; R P Lewis; J Halter; M White
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

View more
  3 in total

Review 1.  Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.

Authors:  P Noone
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

2.  Pharmacology and efficacy of netilmicin.

Authors:  I Trestman; J Parsons; J Santoro; G Goodhart; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

Review 3.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.